4.3 Article

Considerations for Optimal Inhaler Device Selection in Chronic Obstructive Pulmonary Disease

Journal

CLEVELAND CLINIC JOURNAL OF MEDICINE
Volume 85, Issue -, Pages S19-S27

Publisher

CLEVELAND CLINIC
DOI: 10.3949/ccjm.85.s1.04

Keywords

-

Funding

  1. AstraZeneca LP (Wilmington, DE, USA)

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available